{"id":"https://openalex.org/W2145761690","doi":"https://doi.org/10.1200/jco.2014.58.1298","title":"Anti\u2013Vascular Endothelial Growth Factor Therapy in Breast Cancer: Game Over?","display_name":"Anti\u2013Vascular Endothelial Growth Factor Therapy in Breast Cancer: Game Over?","alternate_titles":[],"publication_year":2014,"publication_date":"2014-10-28","ids":{"openalex":"https://openalex.org/W2145761690","doi":"https://doi.org/10.1200/jco.2014.58.1298","mag":"2145761690","pmid":"https://pubmed.ncbi.nlm.nih.gov/25349299"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.58.1298","doi":"https://doi.org/10.1200/jco.2014.58.1298","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2014.58.1298","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.58.1298?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145761690"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.58.1298?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066769011","display_name":"George W. Sledge","orcid":"https://orcid.org/0000-0003-0297-0775","observed_orcids":["https://orcid.org/0000-0003-0297-0775"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"George W. Sledge","raw_affiliation_strings":["Stanford University School of Medicine, Palo Alto, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University School of Medicine, Palo Alto, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5066769011"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":47,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"2","first_page":"133","last_page":"135"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.012799999676644802,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9079999923706055},{"id":"https://openalex.org/keywords/ramucirumab","display_name":"ramucirumab","score":0.8899999856948853},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/vegfr2","display_name":"VEGFR2","score":0.6869999766349792},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8299999833106995},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7039999961853027},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.5120000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8853805065155029},{"id":"https://openalex.org/C2779551604","wikidata":"https://www.wikidata.org/wiki/Q7290345","display_name":"Ramucirumab","level":3,"score":0.8704210519790649},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.8647196292877197},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.8403407335281372},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6958705186843872},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6616334319114685},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6204684376716614},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.5875253081321716},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5813053846359253},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.498551607131958},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44120272994041443},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.42786893248558044},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3157096207141876},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.08293494582176208}],"mesh":[{"descriptor_ui":"D000096662","descriptor_name":"Ramucirumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1200/jco.2014.58.1298","doi":"https://doi.org/10.1200/jco.2014.58.1298","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2014.58.1298","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.58.1298?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:25349299","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25349299","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Editorial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1007.4593","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1007.4593","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://hwmaint.jco.ascopubs.org/cgi/reprint/33/2/133.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1200/jco.2014.58.1298","doi":"https://doi.org/10.1200/jco.2014.58.1298","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2014.58.1298","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2014.58.1298?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2145761690.pdf","grobid_xml":"https://content.openalex.org/works/W2145761690.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1522653250","https://openalex.org/W1554296669","https://openalex.org/W1978291661","https://openalex.org/W2039212876","https://openalex.org/W2039335375","https://openalex.org/W2040975353","https://openalex.org/W2042969122","https://openalex.org/W2055192249","https://openalex.org/W2067969350","https://openalex.org/W2068737632","https://openalex.org/W2085946496","https://openalex.org/W2098276344","https://openalex.org/W2098516378","https://openalex.org/W2099824657","https://openalex.org/W2103551875","https://openalex.org/W2103563357","https://openalex.org/W2103979740","https://openalex.org/W2104759721","https://openalex.org/W2126275851","https://openalex.org/W2130334661","https://openalex.org/W2131705241","https://openalex.org/W2132046158","https://openalex.org/W2135530224","https://openalex.org/W2144574890","https://openalex.org/W2149037161","https://openalex.org/W2167224460","https://openalex.org/W2169435545","https://openalex.org/W2275088062","https://openalex.org/W2329453293","https://openalex.org/W2461425243"],"related_works":["https://openalex.org/W1986179085","https://openalex.org/W2408874543","https://openalex.org/W2094912909","https://openalex.org/W2139716410","https://openalex.org/W2123177825","https://openalex.org/W1965325738","https://openalex.org/W163159489","https://openalex.org/W2020198517","https://openalex.org/W2069368895"],"abstract_inverted_index":{"In":[0],"the":[1,11,25,78,95,106,112,117,122],"article":[2],"that":[3],"accompanies":[4],"this":[5],"editorial,":[6],"Mackey":[7],"et":[8],"al1":[9],"pres-ent":[10],"results":[12,85],"of":[13,27,97],"ROSE/TRIO-12,":[14],"a":[15,127],"randomized":[16],"phase":[17,57],"III":[18,58],"trial":[19,41],"com-paring":[20],"single":[21],"agent":[22,80],"docetaxel":[23,28],"to":[24,81,90,110],"combination":[26],"and":[29],"ramucirumab":[30,61],"in":[31,55,100,119,129],"front-line":[32],"metastatic":[33],"breast":[34,101,113],"cancer.":[35],"This":[36],"large,":[37],"well-powered,":[38],"placebo-controlled":[39],"international":[40],"replaced":[42],"bevacizumab":[43],"(a":[44,62],"vascular":[45],"endothelial":[46],"growth":[47],"factor":[48],"[VEGF]":[49],"\u2013A":[50],"ligand":[51],"blocking":[52],"antibody":[53,71],"used":[54],"numerous":[56],"trials)":[59],"with":[60,121],"human":[63],"immunoglobulin":[64],"G1":[65],"VEGF":[66],"receptor":[67],"[VEGFR]":[68],"\u20132\u2013binding":[69],"monoclonal":[70],"recently":[72],"approved":[73],"for":[74],"gastric":[75],"cancer)":[76],"as":[77],"anti-VEGF":[79,98,108],"be":[82],"studied.":[83],"The":[84],"are":[86],"disappointing":[87],"but":[88],"familiar":[89],"those":[91],"who":[92],"have":[93],"followed":[94],"story":[96],"therapy":[99,109],"cancer\u2014yet":[102],"another":[103],"failure.":[104],"Bevacizumab,":[105],"first":[107],"enter":[111],"cancer":[114],"arena,":[115],"electrified":[116],"field":[118],"2005":[120],"E2100":[123],"trial,":[124],"which":[125],"showed":[126],"doubling":[128],"progression-free":[130],"survival":[131],"(PFS)":[132],"when":[133],"combined":[134]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145761690","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
